PLoS Pathogens (Jan 2021)

Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.

  • Dina Alzhanova,
  • Kathleen Corcoran,
  • Aubrey G Bailey,
  • Kristin Long,
  • Sharon Taft-Benz,
  • Rachel L Graham,
  • Grant S Broussard,
  • Mark Heise,
  • Gabriele Neumann,
  • Peter Halfmann,
  • Yoshihiro Kawaoka,
  • Ralph S Baric,
  • Blossom Damania,
  • Dirk P Dittmer

DOI
https://doi.org/10.1371/journal.ppat.1009033
Journal volume & issue
Vol. 17, no. 1
p. e1009033

Abstract

Read online

The p53 transcription factor plays a key role both in cancer and in the cell-intrinsic response to infections. The ORFEOME project hypothesized that novel p53-virus interactions reside in hitherto uncharacterized, unknown, or hypothetical open reading frames (orfs) of human viruses. Hence, 172 orfs of unknown function from the emerging viruses SARS-Coronavirus, MERS-Coronavirus, influenza, Ebola, Zika (ZIKV), Chikungunya and Kaposi Sarcoma-associated herpesvirus (KSHV) were de novo synthesized, validated and tested in a functional screen of p53 signaling. This screen revealed novel mechanisms of p53 virus interactions and two viral proteins KSHV orf10 and ZIKV NS2A binding to p53. Originally identified as the target of small DNA tumor viruses, these experiments reinforce the notion that all viruses, including RNA viruses, interfere with p53 functions. These results validate this resource for analogous systems biology approaches to identify functional properties of uncharacterized viral proteins, long non-coding RNAs and micro RNAs.